Immunopathology of multiple sclerosis

Dendrou, Calliope A., Fugger, Lars, Friese, Manuel A.·2015·Nature Reviews Immunology

DOI 10.1038/nri3871

Cited by (1,003)

Items 701–800 of 1,003

MicroRNA-150 targets PU.1 and regulates macrophage differentiation and function in experimental autoimmune encephalomyelitis
Leila Shakerian, Samira Ghorbani, Farideh Talebi, Farshid Noorbakhsh · 2018 · Journal of Neuroimmunology
The Place of Transcranial Direct Current Stimulation in the Management of Multiple Sclerosis-Related Symptoms
Samar S. Ayache, Moussa A. Chalah · 2018 · Neurodegenerative Disease Management
Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models
M. Elizabeth Deerhake, Debolina D. Biswas, William E. Barclay, Mari L. Shinohara · 2019 · Frontiers in Immunology
The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
Simon D. Goldenberg, Blair Merrick · 2021 · Therapeutic Advances in Infectious Disease
Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment
Marianna Gabriella Rispoli, Silvia Valentinuzzi, Giovanna De Luca, Piero Del Boccio, Luca Federici, Maria di Ioia, Anna Digiovanni, Eleonora Agata Grasso, Valeria Pozzilli, Alessandro Villani et al. · 2021 · International Journal of Molecular Sciences
Construction of a lncRNA–miRNA–mRNA Network to Determine the Key Regulators of the Th1/Th2 Imbalance in Multiple Sclerosis
Hanieh Azari, Elham Karimi, Mohammad Shekari, Ahmad Tahmasebi, Amin Reza Nikpoor, Ahmad Agha Negahi, Nima Sanadgol, Pegah Mousavi · 2021 · Epigenomics
Multiple Sclerosis Following SARS-CoV-2 Infection: A Case Report and Literature Review
Sobia Sarwar, Sylvette Rogers, Alaa Sayed Mohamed, Enitare Ogula, Rihanat A Ayantayo, Ahmed Ahmed, Iram Shahzadi, Saurabh Kataria, Romil Singh · 2021 · Cureus
Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data
Serena Ruggieri, Maria Esmeralda Quartuccio, Luca Prosperini · 2022 · Degenerative Neurological and Neuromuscular Disease
GABA B receptor agonist baclofen promotes central nervous system remyelination
Mari Paz Serrano‐Regal, Laura Bayón‐Cordero, Juan Carlos Chara Ventura, Blanca Isabel Ochoa-Bueno, Vanja Tepavčević, Carlos Matute, María Victoria Sánchez‐Gómez · 2022 · Glia
Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity
Alexandra E Oppong, Leda Coelewij, Georgia Robertson, Lucia Martin‐Gutierrez, Kirsty E. Waddington, Pierre Dönnes, Petra Nytrová, Rachel A Farrell, Inès Pineda‐Torra, Elizabeth C. Jury · 2024 · iScience
CNS Resident Innate Immune Cells: Guardians of CNS Homeostasis
Luca Muzio, Jessica Perego · 2024 · International Journal of Molecular Sciences
Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate
Amandine Mathias, Sylvain Perriot, Mathieu Canales, Claudia Blatti, Coline Gaubicher, Myriam Schluep, Britta Engelhardt, Renaud Du Pasquier · 2017 · Neurology Neuroimmunology & Neuroinflammation
Microglia P2X4 receptors as pharmacological targets for demyelinating diseases
Francesco Di Virgilio, Alba Clara Sarti · 2018 · EMBO Molecular Medicine
Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease
Kaitlyn Koenig Thompson, Jillian C. Nissen, Amanda Pretory, Stella E. Tsirka · 2018 · Frontiers in Immunology
The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis
Mahmood Yaseen Hachim, Noha Mousaad Elemam, Azzam A. Maghazachi · 2019 · Toxins
Systemic Mesenchymal Stem Cell Treatment Mitigates Structural and Functional Retinal Ganglion Cell Degeneration in a Mouse Model of Multiple Sclerosis
Oliver W. Gramlich, Alexander J. Brown, Cheyanne R. Godwin, Michael S. Chimenti, Lauren K. Boland, James A. Ankrum, Randy H. Kardon · 2020 · Translational Vision Science & Technology
Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells
Isaac J. Jensen, Samantha N. Jensen, Frances V. Sjaastad, Katherine Nicole Gibson-Corley, Thamotharampillai Dileepan, Thomas S. Griffith, Ashutosh Kumar Mangalam, Vladimir P. Badovinac · 2020 · eLife
Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation
Joseph-Patrick W. E. Clarke, Patricia A. Thibault, Hannah E. Salapa, David E. Kim, Catherine Hutchinson, Michael C. Levin · 2021 · International Journal of Molecular Sciences
Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectations
Julia Krämer, Heinz Wiendl · 2024 · Current Opinion in Neurology
Primary Progressive Multiple Sclerosis—A Key to Understanding and Managing Disease Progression
Izabela Sempik, Edyta Dziadkowiak, Helena Moreira, Anna Zimny, Anna Pokryszko‐Dragan · 2024 · International Journal of Molecular Sciences
Role of innate immune cells in multiple sclerosis
Carolina E. Prado, Andrés A. Herrada, Daniel Hevia, Lorna Galleguillos, Noelia Escobedo · 2025 · Frontiers in Immunology
Comparative analysis of neuroinflammatory pathways in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis: insights into similarities and distinctions
Julia Doroszkiewicz, Izabela Winkel, Barbara Mroczko · 2025 · Frontiers in Neuroscience
Acid-sensing ion channels: structure, function, pharmacology, and clinical significance
Lachlan D. Rash, Stephan Kellenberger · 2025 · Physiological Reviews
Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence
Mahshid Yeganeh Salehpour, Adriano Mollica, Saeideh Momtaz, Nima Sanadgol, Mohammad Hosein Farzaei · 2019 · Clinical Drug Investigation
Epigenetics in Multiple Sclerosis
Vera S. F. Chan · 2020 · Advances in experimental medicine and biology
The effects of aging and disease duration on cognition in multiple sclerosis
Alexandra Tremblay, Kim Charest, Estefania Brando, Élise Roger, Pierre Duquette, Isabelle Rouleau · 2020 · Brain and Cognition
The STING-IFN-β-Dependent Axis Is Markedly Low in Patients with Relapsing-Remitting Multiple Sclerosis
Lars Masanneck, Susann Eichler, Anna Vogelsang, Melanie Korsen, Heinz Wiendl, Thomas Budde, Sven Guenther Meuth · 2020 · International Journal of Molecular Sciences
GAS6 signaling tempers Th17 development in patients with multiple sclerosis and helminth infection
Juan M. Ortiz Wilczyñski, Cinthia Mariel Olexen, Andrea Emilse Errasti, Mirta A. Schattner, Carla Vanina Rothlin, Jorge Daniel Correale, Eugenio Antonio Carrera Silva · 2020 · PLoS Pathogens
PRMT5 Promotes Cyclin E1 and Cell Cycle Progression in CD4 Th1 Cells and Correlates With EAE Severity
Stephanie A. Amici, Wissam Osman, Mireia Guerau‐de‐Arellano · 2021 · Frontiers in Immunology
Lactate Threshold Training Program on Patients with Multiple Sclerosis: A Multidisciplinary Approach
Alessandra Amato, Paolo Ragonese, Sonia Ingoglia, Gabriella Schiera, Giuseppe Schirò, Carlo Maria Di Liegro, Giuseppe Salemi, Italia Di Liegro, Patrizia Proia · 2021 · Nutrients
Acetyl-11-keto-β-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-κB pathways in SJL/J mouse model of experimental autoimmune encephalomyelitis
Ahmed Nadeem, Sheikh F. Ahmad, Naif Obaid Al-Harbi, Wedad S. Sarawi, Sabry Mohamed Attia, Wael A. Alanazi, Khalid E. Ibrahim, Sary Alsanea, Saleh Abdullah Alqarni, Ali S. Alfardan et al. · 2022 · International Immunopharmacology
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
Ingrid Anne Lie, Kristin Wesnes, Silje Stokke Kvistad, Iman Brouwer, Stig Wergeland, Trygve Holmøy, Rune Midgard, Alla Bru, Astrid Edland, Randi Eikeland et al. · 2022 · Neurology Neuroimmunology & Neuroinflammation
Neuroinflammation: Extinguishing a blaze of T cells
Naïl Benallegue, Hania Kébir, Jorge Ivan Alvarez · 2022 · Immunological Reviews
Interleukin 22 and its association with neurodegenerative disease activity
Wenjian Chen, Jianpeng Wang, Huaizhi Yang, Yuankai Sun, Bangjie Chen, Yuchen Liu, Yanxun Han, Ming Shan, Junfeng Zhan · 2022 · Frontiers in Pharmacology
Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational study
Marijn Huiskamp, Svenja Kiljan, Shanna D. Kulik, Maarten E. Witte, Laura E. Jonkman, John G. J. M. Bol, Geert J. Schenk, Hanneke E. Hulst, Prejaas K. B. Tewarie, Menno Michiel Schoonheim et al. · 2022 · Multiple Sclerosis Journal
The role of systemic ımmune ınflammatory ındex in showing active lesion ın patients with multiple sclerosis
Şeyda Figül Gökçe, Aslı Bolayır, Burhanettin Çiğdem, Bulent Yildiz · 2023 · BMC Neurology
Ivermectin Protects Against Experimental Autoimmune Encephalomyelitis in Mice by Modulating the Th17/Treg Balance Involved in the IL-2/STAT5 Pathway
Yu Xie, Chaolei Jin, Hongzhen Sang, Wenhua Liu, Junpeng Wang · 2023 · Inflammation
Intermittent Fasting on Neurologic Diseases: Potential Role of Gut Microbiota
Mingke Guo, Xuan Wang, Yujuan Li, Ailin Luo, Yilin Zhao, Xiaoxiao Luo, Shiyong Li · 2023 · Nutrients
Propionic acid promotes neurite recovery in damaged multiple sclerosis neurons
Barbara Gisevius, Alexander Duscha, Gereon Poschmann, Kai Stühler, Jeremias Motte, Anna Lena Fisse, Sanja Augustyniak, Adriana Rehm, Pia Renk, Celina Böse et al. · 2024 · Brain Communications
Inflammation at the blood-brain barrier: The role of liver X receptors
Nienke M. de Wit, Jasmine Vanmol, Alwin Kamermans, Jerome J. A. Hendriks, Helga E. de Vries · 2016 · Neurobiology of Disease
Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation
Gislane Lelis Vilela de Oliveira, Aline Fernanda Ferreira, Elainy Patrícia Lino Gasparotto, Simone Haddad Kashima, Dimas Tadeu Covas, Carlos Tostes Guerreiro, Doralina Guimarães Brum, Amilton Antunes Barreira, Júlio César Voltarelli, Belinda Pinto Simões et al. · 2016 · Clinical & Experimental Immunology
Dynamical footprint of cross-reactivity in a human autoimmune T-cell receptor
Amit Kumar, Francesco Delogu · 2017 · Scientific Reports
Biological determinants of health: Genes, microbes, and metabolism exemplars of nursing science
Erin Poe Ferranti, Ruth E. Grossmann, Angela Renee Starkweather, Margaret McLean Heitkemper · 2017 · Nursing Outlook
Is Targeting the Inflammasome a Way Forward for Neuroscience Drug Discovery?
Tessa Swanton, James Cook, James A. Beswick, Sally Freeman, Catherine B. Lawrence, David Brough · 2018 · SLAS DISCOVERY
Induction treatment strategy in multiple sclerosis: a review of past experiences and future perspectives
Serena Ruggieri, Simona Pontecorvo, Carla Tortorella, Claudio Gasperini · 2018 · Multiple Sclerosis and Demyelinating Disorders
Regional and functional heterogeneity of antigen presenting cells in the mouse brain and meninges
Samantha J. Dando, Renee Kazanis, Holly Rose Chinnery, Paul Gerard McMenamin · 2018 · Glia
A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene
Michael Hecker, Nina Boxberger, Nicole Illner, Brit Fitzner, Ina Schröder, Alexander Winkelmann, Aleš Dudešek, Stefanie Meister, Dirk Koczan, Peter Lorenz et al. · 2019 · PLoS Genetics
Feasibility of a smartphone app to enhance physical activity in progressive MS: a pilot randomized controlled pilot trial over three months
N Nasseri, Eghbal Ghezelbash, Yuyang Zhai, Stefan Patra, Karin Riemann-Lorenz, Christoph Heesen, Anne Christin Rahn, Jan‐Patrick Stellmann · 2020 · PeerJ
Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue
Michela Spadaro, Serena Martire, Luca Marozio, Daniela Mastromauro, Elena Montanari, Simona Perga, Francesca Montarolo, Federica Brescia, Alessia Balbo, Giovanni Botta et al. · 2019 · Frontiers in Immunology
CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis
Anne Skøttrup Mørkholt, Michael Sloth Trabjerg, Michal Krystian Oklinski, Luise Bolther, Lona John Kroese, Colin E.J. Pritchard, Ivo Johan Huijbers, John D. Nieland · 2019 · Scientific Reports
Analysis of defective pathways and drug repositioning in Multiple Sclerosis via machine learning approaches
Enrique J. deAndrés‐Galiana, Guillermina Bea, Juan Luis Fernández‐Martínez, Leorey N. Saligan · 2019 · Computers in Biology and Medicine
Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model
Bing Han, Yanyan Zhang, Ze‐Qing Ye, Yun Xiao, Javad Rasouli, Wen‐Cheng Wu, Sumin Ye, Xin‐Yue Guo, Lin Zhu, Abdolmohamad M. Rostami et al. · 2021 · Immunology
Possible Role of Butyrylcholinesterase in Fat Loss and Decreases in Inflammatory Levels in Patients with Multiple Sclerosis after Treatment with Epigallocatechin Gallate and Coconut Oil: A Pilot Study
José Enrique de la Rubia Ortí, José Luis Platero, Iván Hu Yang, J. M. Castro Cerón, Asta Tvarijonaviciute, Pablo Selvi-Sabater, María Benlloch, David Sancho-Cantus, Sandra Sancho-Castillo · 2021 · Nutrients
Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis
Malik R. Seals, Monica M. Moran, Jonathan D. Leavenworth, Jianmei W. Leavenworth · 2022 · Frontiers in Immunology
Efficacy of surgical treatment in patients with trigeminal neuralgia secondary to multiple sclerosis: A prospective study of 18 cases with evaluation of outcome and complications by independent evaluators
Jacob Worm, Navid Noory, Emil Andonov Smilkov, Tone Bruvik Heinskou, Anne Sofie Schott Andersen, Jacob Bertram Springborg, Per Rochat, Jette Lautrup Frederiksen, Lars Bendtsen, Stine Maarbjerg · 2023 · Cephalalgia
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum
Klaus Berek, Angelika Bauer, Dagmar Rudzki, Michael Auer, Robert Barket, Anne Zinganell, Magdalena Lerch, Livia Hofer, Astrid Ellen Grams, Paulina Poskaite et al. · 2023 · Frontiers in Immunology
The spectral slope as a marker of excitation/inhibition ratio and cognitive functioning in multiple sclerosis
Fahimeh Akbarian, Chiara Rossi, Lars Costers, Marie Beatrice D'hooghe, Miguel D’haeseleer, Guy Nagels, Jeroen Van Schependom · 2023 · Human Brain Mapping
Smart Nanoscale Extracellular Vesicles in the Brain: Unveiling their Biology, Diagnostic Potential, and Therapeutic Applications
Akanksha Onkar, Fatima Khan, Anshika Goenka, Ramya Lakshmi Rajendran, Crismita Dmello, Chae Moon Hong, Nida Mubin, Prakash Gangadaran, Byeong‐Cheol Ahn · 2024 · ACS Applied Materials & Interfaces
Gut–Brain Interactions and Their Impact on Astrocytes in the Context of Multiple Sclerosis and Beyond
Julia Zißler, Veit Rothhammer, Mathias Linnerbauer · 2024 · Cells
Intrathecal insulin-like growth factor 1 but not insulin enhances myelin repair in young and aged rats
Hlavica, Martin, Delparente, Aro, Good, Andrin, Good, Nicolas, Plattner, Patricia S., Seyedsadr, Maryam S., Schwab, Martin E., Figlewicz, Dianne P., Ineichen, Benjamin V. · 2017 · Neuroscience Letters
Myelin Basic Protein Citrullination, a Hallmark of Central Nervous System Demyelination, Assessed by Novel Monoclonal Antibodies in Prion Diseases
Byungki Jang, Yong‐Chul Jeon, Hae‐Young Shin, Yun-Jung Lee, Hyun‐Ji Kim, Yoshitaka Kondo, Akihito Ishigami, Yong‐Sun Kim, Eun‐Kyoung Choi · 2017 · Molecular Neurobiology
Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial
Justin B McKee, Charles L. Cottriall, John S Elston, Simon J. Epps, Nikos Evangelou, Stephen Gerry, Christopher Kennard, Yazhuo Kong, Abby Koelewyn, Wilhelm Kueker et al. · 2017 · Multiple Sclerosis Journal
Multiple sclerosis pathogenesis: missing pieces of an old puzzle
Reza Rahmanzadeh, Wolfgang Brück, Alireza Minagar, Mohammad Ali Sahraian · 2018 · Reviews in the Neurosciences
Estrogen Signaling in Bystander Foxp3neg CD4+ T Cells Suppresses Cognate Th17 Differentiation in Trans and Protects from Central Nervous System Autoimmunity
Laure Garnier, Sophie Laffont, Karine Lélu, Nir Yogev, Ari Waisman, Jean‐Charles Guéry · 2018 · The Journal of Immunology
Regular Exercise Modifies Histopathological Outcomes of Pharmacological Treatment in Experimental Autoimmune Encephalomyelitis
Danielle Bernardes, Alexandre Leite Rodrigues de Oliveira · 2018 · Frontiers in Neurology
TRPM8 channel inhibitor AMTB suppresses murine T-cell activation induced by T-cell receptor stimulation, concanavalin A, or external antigen re-stimulation
Honoka Kume, Mitsutoshi Tsukimoto · 2019 · Biochemical and Biophysical Research Communications
T Cell Repertoire Dynamics during Pregnancy in Multiple Sclerosis
Caren Ramien, Erik C. Yusko, Jan Broder Engler, Stefanie Gamradt, Kostas Patas, Nils Schweingruber, Anne Willing, Sina Cathérine Rosenkranz, Anke Diemert, Anja Harrison et al. · 2019 · Cell Reports
A computational approach based on the colored Petri net formalism for studying multiple sclerosis
Simone Pernice, Marzio Alfio Pennisi, Greta Romano, Alessandro Maglione, Santina Cutrupi, Francesco Pappalardo, Gianfranco Balbo, Marco Beccuti, Francesca Cordero, Raffaele Calogero · 2019 · BMC Bioinformatics
Natural product piperine alleviates experimental allergic encephalomyelitis in mice by targeting dihydroorotate dehydrogenase
Zehui Liu, Qian Hu, Wanyan Wang, Sisi Lu, Dang Wu, Shuyin Ze, Jiacheng He, Ying Huang, Wuyan Chen, Yechun Xu et al. · 2020 · Biochemical Pharmacology
Disease‐modifying agents for multiple sclerosis and the risk for reporting cancer: A disproportionality analysis using the US Food and Drug Administration Adverse Event Reporting System database
Vasileios‐Periklis Stamatellos, Spyridon Siafis, Georgios Papazisis · 2021 · British Journal of Clinical Pharmacology
Natalizumab differentially affects plasmablasts and B cells in multiple sclerosis
Alexander Cuculiza Henriksen, Cecilie Ammitzbøll, Eva Rosa Petersen, Oskar Hoffmann McWilliam, Finn Thorup Sellebjerg, Marina Rode von Essen, Jeppe Romme Christensen · 2021 · Multiple Sclerosis and Related Disorders
A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis
Ameneh Shokati, Abdorreza Naser Moghadasi, Mohsen Nikbakht, Mohammad Ali Sahraian, Seyed Asadollah Mousavi, Jafar Ai · 2021 · Stem Cell Research & Therapy
An optimized and validated protocol for inducing chronic experimental autoimmune encephalomyelitis in C57BL/6J mice
Huntemann, Niklas, Vogelsang, Anna, Groeneweg, Linda, Willison, Alice, Herrmann, Alexander M., Meuth, Sven G., Eichler, Susann · 2022 · Journal of Neuroscience Methods
Axonal damage in spinal cord is associated with gray matter atrophy in sensorimotor cortex in experimental autoimmune encephalomyelitis
Cassandra Meyer, Josephine L. Gao, James Ying-Jie Cheng, Mandavi R. Oberoi, Hadley Johnsonbaugh, Stefano Lepore, Florian Kurth, Mackenzie J. Thurston, Noriko Itoh, Kevin R. Patel et al. · 2019 · Multiple Sclerosis Journal
Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders
Chad J. Pickens, Matthew A. Christopher, Martin A. Leon, Melissa M. Pressnall, Stephanie N. Johnson, Sharadvi Thati, Bradley P. Sullivan, Cory J. Berkland · 2019 · Molecular Pharmaceutics
Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients
Murat Kürtüncü, Vuslat Yılmaz, Halil İbrahim Akçay, Recai Türkoğlu, Burcu Altunrende, Suzan Çınar, Canan Aysel Ulusoy, Tuncay Gündüz, Sema İçöz, Mithat Kasap et al. · 2019 · Journal of Neuroimmunology
Spinal Cord Involvement in MS and Other Demyelinating Diseases
Mariano Marrodán, María Inés Gaitán, Jorge Daniel Correale · 2020 · Biomedicines
Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach
Tianrong Yeo, Fay Probert, Megan A. Sealey, Luisa Saldana, Ruth Geraldes, Sebastian Höckner, Eric Schiffer, Timothy D. W. Claridge, David Leppert, Gabriele C. DeLuca et al. · 2021 · Brain Communications
The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis
Alice Willison, Tobias Ruck, Georg Lenz, Hans‐Peter Hartung, Sven Guenther Meuth · 2022 · Journal of Neurology
Intranasal delivery of a small-molecule ErbB inhibitor promotes recovery from acute and late-stage CNS inflammation
Mathias Linnerbauer, Lena Lößlein, Oliver Vandrey, Thanos Tsaktanis, Alexander Beer, Ulrike J. Naumann, Franziska Panier, Tobias Beyer, Lucy Nirschl, Joji B. Kuramatsu et al. · 2022 · JCI Insight
Dissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets
Michael H. Guo, Prashanth Sama, Brenna A. LaBarre, Hrishikesh A. Lokhande, John Balibalos, Ci Chu, Xiaomi Du, Pouya Kheradpour, Charles C. Kim, Taylor K. Oniskey et al. · 2022 · Genome biology
Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases
Jung-Won Shin · 2023 · encephalitis
Astrocyte-Derived Exosomes Differentially Shape T Cells’ Immune Response in MS Patients
Piotr Szpakowski, Dominika Justyna Ksiazek-Winiarek, Joanna Czpakowska, Mateusz Kałuża, Marta Milewska-Jędrzejczak, Andrzej R Glabinski · 2023 · International Journal of Molecular Sciences
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
Joke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, Miguel D’haeseleer · 2023 · Frontiers in Immunology
Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases
Jianshu Zhu, Jiawei Fan, Yuanliang Xia, Hengyi Wang, Yuehong Li, Zijia Feng, Changfeng Fu · 2023 · Frontiers in Immunology
Vagus nerve stimulation enhances remyelination and decreases innate neuroinflammation in lysolecithin-induced demyelination
Helen Bachmann, Boris Vandemoortele, Vanessa Vermeirssen, Evelien Carrette, Kristl E.J. Vonck, Paul Boon, Robrecht Raedt, Guy Laureys · 2024 · Brain stimulation
Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females
Brendan Cordeiro, Jeeyoon Jennifer Ahn, Saurabh Gawde, Carmen C. Ucciferri, Nuria Álvarez‐Sánchez, Xavier S. Revelo, Natalie H. Stickle, Kaylea Massey, David G. Brooks, Joel M. Guthridge et al. · 2024 · Cell Metabolism
Dysregulated T cells in multiple sclerosis
Norio Chihara · 2018 · Clinical and Experimental Neuroimmunology
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis
Nicole Ziliotto, Marcello Baroni, Sofía Straudi, Fabio Manfredini, Rosella Mari, Erica Menegatti, Rebecca Voltan, Paola Secchiero, Paolo Zamboni, Nino Basaglia et al. · 2018 · Frontiers in Neurology
The role of inflammation in subventricular zone cancer
Chiara Bardella, Abeer R. Al‐Shammari, Luana Campos Soares, Ian P.M. Tomlinson, Eric E. O’Neill, Francis G. Szele · 2018 · Progress in Neurobiology
Is the Limit-Cycle-Attractor an (almost) invariable characteristic in human walking?
Kim‐Charline Broscheid, Christian Dettmers, Manfred Vieten · 2018 · Gait & Posture
Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients
Marsilio Adriani, Petra Nytrová, Cyprien Mbogning, Signe Hässler, Karel Medek, Poul Erik Jensen, Paul I. Creeke, Clemens Warnke, Kathleen Ingenhoven, Bernhard Hemmer et al. · 2018 · JCI Insight
Expression analysis of long non-coding RNAs and their target genes in multiple sclerosis patients
Maziar Ganji, Arezou Sayad, Mir Davood Omrani, Shahram Arsang‐Jang, Mehrdokht Mazdeh, Mohammad Naser Taheri · 2019 · Neurological Sciences
Cross-reactivity between myelin oligodendrocyte glycoprotein and human endogenous retrovirus W protein: nanotechnological evidence for the potential trigger of multiple sclerosis
Vanessa de Luca, Akemi Martins Higa, Camila Malta Romano, Giovanni Pimenta Mambrini, Luis Antônio Peroni, Francisco Trivinho‐Strixino, Fábio L. Leite · 2019 · Micron
A Microfluidic Human Model of Blood–Brain Barrier Employing Primary Human Astrocytes
Eliana Lauranzano, Elena Campo, Marco Rasile, Raffaella Molteni, Marco Pizzocri, Lorena Passoni, Lorenzo Bello, Davide Pozzi, Ruggero Pardi, Michela Matteoli et al. · 2019 · Advanced Biosystems
Immunoengineering approaches for cytokine therapy
Aslan Mansurov, Abigail L. Lauterbach, Erica Budina, Aaron T. Alpar, Jeffrey A. Hubbell, Jun Ishihara · 2021 · American Journal of Physiology-Cell Physiology
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis
Guadalupi, Livia, Mandolesi, Georgia, Vanni, Valentina, Balletta, Sara, Caioli, Silvia, Pavlovic, Anto, De Vito, Francesca, Fresegna, Diego, Sanna, Krizia, Vitiello, Laura et al. · 2024 · Neuropharmacology
MicroRNA-92a–CPEB3 axis protects neurons against inflammatory neurodegeneration
Winkler, Iris, Engler, Jan Broder, Vieira, Vanessa, Bauer, Simone, Liu, Yi-Hsiang, Di Liberto, Giovanni, Grochowska, Katarzyna M., Wagner, Ingrid, Bier, Jasmina, Bal, Lukas C. et al. · 2023 · Science Advances
Role of ferroptosis in neuroimmunity and neurodegeneration in multiple sclerosis revealed by multi‐omics data
Wu, Tao, Ning, Shangwei, Zhang, Huixue, Cao, Yuze, Li, Xia, Hao, Junwei, Wang, Lihua · 2024 · Journal of Cellular and Molecular Medicine
Fatores ambientais envolvidos na Fisiopatologia da Esclerose Múltipla: uma revisão bibliográfica / Environmental factors involved in the Pathophysiology of Multiple Sclerosis: a bibliographic review
Letícia Gonçalves Carvalho, Letícia Raiane Fogari, Maria Eduarda Leati Caparroz, Adriana Balbina Paoliello · 2022 · Brazilian Journal of Health Review